Filtered By:
Cancer: Lymphoma

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 56 results found since Jan 2013.

Why corruption is ruining your health care PODCAST
“Doctors help patients, and they love us for it. We fix bones, replace joints, cure killer infections, and control diabetes with insulin. We use painless scans for diagnosis. Liver, kidney, and heart transplants are now routine. Some patients get cured of lymphomas, leukemia, Hodgkin ’s disease, and testicular cancer. Lives are prolonged for myeloma and amyloidosis. […]Find jobs at  Careers by KevinMD.com.  Search thousands of physician, PA, NP, and CRNA jobs now.  Learn more.
Source: Kevin, M.D. - Medical Weblog - December 25, 2020 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/blog/post-author/the-podcast-by-kevinmd" rel="tag" > The Podcast by KevinMD < /a > < /span > Tags: Podcast Public Health & Policy Source Type: blogs

TWiV 344: Glasgwegians go viral
Host: Vincent Racaniello Guests: Ruth Jarrett, Glen Nemerow, and Esther Schnettler At the Glasgow Science Festival microTALKS, Vincent speaks with Ruth, Glen, and Esther about their research on viruses and Hodgkin lymphoma, adenovirus structure and entry into cells, and interactions between arthropod borne viruses and their hosts. Links for this episode Glasgow Science Festival microTALKS Hodgkin lymphoma (Histopath) HHV-6 and Hodgkin lymphoma (PLoS One) Adenovirus entry (PLoS Path) Adenovirus membrane penetration (Virology) Mosquito pathways that limit CHIK replication (PLoS Negl Trop Dis) Tick antiviral...
Source: This Week in Virology - MP3 Edition - July 5, 2015 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain Metastasis
AbstractBrain metastases are especially common in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC), with a cumulative incidence of over 50% and associated with a poor prognosis, high symptom burden, and decreased quality of life. Lorlatinib is a brain-penetrant, third-generation ALK tyrosine kinase inhibitor (TKI), which has a high potency against resistance mutations seen with earlier generation ALK TKIs. In 2018, lorlatinib was granted accelerated approval in second- and third-line treatment for use in patients withALK-positive metastatic NSCLC on the basis of phase  1/2 study results. This i...
Source: Advances in Therapy - August 12, 2023 Category: Drugs & Pharmacology Source Type: research

The LITFL Review 095
Welcome to the challenging 95th edition! The LITFL Review is your regular and reliable source for the highest highlights, sneakiest sneak peaks and loudest shout-outs from the webbed world of emergency medicine and critical care. Each week the LITFL team casts the spotlight on the best and brightest from the blogosphere, the podcast video/audiosphere and the rest of the Web 2.0 social media jungle to find the most fantastic EM/CC FOAM (Free Open Access Meducation) around. The Most Fair Dinkum Ripper Beaut of the Week emimdoc Top spot this week heads over to David at emimdoc with his post on A Note to Conference Organiz...
Source: Life in the Fast Lane - February 18, 2013 Category: Emergency Medicine Doctors Authors: Kane Guthrie Tags: Education eLearning Emergency Medicine Featured Health Intensive Care LITFL review LITFL R/V Source Type: blogs

LITFL Review 269
Welcome to the 269th LITFL Review! Your regular and reliable source for the highest highlights, sneakiest sneak peeks and loudest shout-outs from the webbed world of emergency medicine and critical care. Each week the LITFL team casts the spotlight on the blogosphere’s best and brightest and deliver a bite-sized chunk of FOAM. The Most Fair Dinkum Ripper Beauts of the Week Rinaldo Bellomo delivers a mind-blowing talk on glycaemic control in the critically ill. A must listen. [SO] The Best of #FOAMed Emergency Medicine Can we use the d-dimer to rule out aortic dissection? First10EM + EMCases feature a deep dive in...
Source: Life in the Fast Lane - February 12, 2017 Category: Emergency Medicine Authors: Marjorie Lazoff, MD Tags: Education LITFL review Source Type: blogs

TWiV 374: Discordance in B
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler The TWiVniks consider the role of a cell enzyme that removes a protein linked to the 5'-end of the picornavirus genome, and the connection between malaria, Epstein-Barr virus, and endemic Burkitt's lymphoma.   Links for this episode Divergent requirements for removing VPg (mBio) Bond, covalent bond (TWiV 210) Link between malaria and endemic Burkitt's lymphoma (PLoS Path) Multifactorial role of malaria in Burkitt's lymphoma (PLoS Path) Plasmodium infection promotes AID-dependent B cell lymphoma (Cell) Children's cance...
Source: This Week in Virology - MP3 Edition - January 31, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts

Mp3: role of histone deactylase (hdac) inhibitors in adult t-cell lymphoma/leukemia (atl)
Conclusions In our small experience of romidepsin in relapsed/refractory ATL, patients appear to have modest response rates and higher rate of cytopenias when compared to other PTCL subtypes in clinical trials. Given the concerns for viral reactivation and lack of data for use of romidepsin in ATL, it should be used cautiously.
Source: Journal of Investigative Medicine - February 25, 2016 Category: Research Authors: Mukhi, N., Sidhu, G., Gonsky, J., Shapira, I. Tags: Moderated Poster, 11:45 PM - 1:05 PM, Wednesday, April 13, 2016 Source Type: research

Podcast Science Signaling Podcast: 3 February 2015
Wnt signaling inhibitors could be used to treat a common type of lymphoma.
Source: Signal Transduction Knowledge Environment - February 5, 2015 Category: Science Authors: Matthew P. Walker, Michael B. Major, Annalisa M. VanHook Source Type: news

#367 : jesse vs. cancer
When stand-up comedian Jesse Case was diagnosed with Stage IV colon cancer in June, he opted to share his experiences with the world via podcast. Jesse joins us to discuss his now viral podcast "Jesse vs. Cancer". Survivor Spotlight on Hodgkin's Lymphoma survivor Jacqueline Piccolo.
Source: The Stupid Cancer Show - Blog Talk Radio - November 24, 2015 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

You Can Cut Your Cancer Risk By Eating Organic, New Study Says
(CNN) — You can protect yourself from cancer by eating organic, a new study suggests. Those who frequently eat organic foods lowered their overall risk of developing cancer, a study published Monday in JAMA Internal Medicine finds. Specifically, those who primarily eat organic foods were more likely to ward off non-Hodgkin lymphoma and postmenopausal breast cancer compared to those who rarely or never ate organic foods. Led by Julia Baudry, an epidemiologist at Institut National de la Sante et de la Recherche Medicale in France, a team of researchers looked at the diets of 68,946 French adults. More than three-quarte...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 22, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cancer Local TV Organic Source Type: news

#367 : jesse vs. cancer
When stand-up comedian Jesse Case was diagnosed with Stage IV colon cancer in June, he opted to share his experiences with the world via podcast. Jesse joins us to discuss his now viral podcast "Jesse vs. Cancer". Survivor Spotlight on Hodgkin's Lymphoma survivor Jacqueline Piccolo.
Source: The Stupid Cancer Show - Blog Talk Radio - November 24, 2015 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts

Limit Therapy to Cure Limited-Stage HL?
Dr. John Radford discusses the RAPID trial, which suggests that PET scans may identify early-stage Hodgkin lymphoma patients who can be cured by chemotherapy alone, without radiotherapy.
Source: Medscape Radiology Podcast - January 7, 2013 Category: Radiology Authors: Medscape Source Type: podcasts

BTK Inhibitors Open Door to Lymphoma Cure
Dr. Bruce Cheson reports on a plethora of data presented at ASH 2012 that heralds what he considers a new era in lymphoma management, one in which a cure may be in sight.
Source: Medscape Medscape Podcast - February 5, 2013 Category: Journals (General) Authors: Medscape Source Type: podcasts

Anas Younes, MD - Lymphoma Management in Evolution: Profiling and Assessing Trends in Patient Care
Lymphoma Management in Evolution: Profiling and Assessing Trends in Patient Care
Source: PeerView CME/CE Audio Podcast - Oncology - January 9, 2013 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts